New Study Shows Little Progress in Keeping Youth Away from Electronic Cigarettes in the United States

Oct.11.2022
New Study Shows Little Progress in Keeping Youth Away from Electronic Cigarettes in the United States
The latest study on youth vaping in the US shows little progress in preventing teens from using e-cigarettes.

A new study conducted by the US government on the use of e-cigarettes among youth has shown little progress in keeping teenagers away from vaping. The survey, which was released on Thursday, suggests that more high school students are using e-cigarettes, with 14% of them reporting recent use compared to 11% in the previous year.


However, experts warn that changes in the survey make comparisons difficult: this year, there is a much higher proportion of participants surveyed in schools, and there are often more reports of e-cigarette use in schools than at home. "Assessing trends (in e-cigarette use) since the outbreak of the pandemic remains difficult," said Alyssa Harlow, a researcher at the University of Southern California who studies adolescent e-cigarette use.


Although there are still many young people using e-cigarettes, they don't seem to be as popular as before. In 2019, 28% of high school students reported having recently used e-cigarettes. For educators, e-cigarettes remain a major issue.


Interestingly, the 2021-22 academic year is worse than pre-pandemic times, according to Mike Rinaldi, the principal of Westhill High School in Connecticut. He notes that it is the first year for many students returning from remote learning during the pandemic and speculates that some may have turned to e-cigarettes to cope with pandemic-related mental health issues or stress. Matt Forker, principal of Stamford High School, says that kids vaping in school bathrooms and stairwells remains a "persistent challenge".


Researchers from the Centers for Disease Control and Prevention authored a new study based on an online survey conducted from January 18th to May 31st of approximately 28,000 American high school students. The study inquired about the use of electronic cigarettes and other vaping devices in the past 30 days. In addition to 14% of high schoolers reporting recent use of e-cigarettes, around 3% of middle schoolers reported having tried them. Among those who used e-cigarettes, approximately 28% reported daily use. Nearly 85% of young people using e-cigarettes used flavored products, with Puff Bar and Vuse being the most popular brands followed by Hyde and Smok.


After months of pressure from congressional members and parents, the US Food and Drug Administration (FDA) took action against the manufacturers of Puff Bar and Hyde on Thursday. The agency sent a warning letter to Puff Bar manufacturer, EVO Brands, stating that the company had not obtained permission to sell their products in the US and that they were being illegally sold. Only a few e-cigarette companies have received FDA approval, which is only granted to products that are beneficial to the health of adult smokers.


The agency also stated that following the denial of their FDA authorization application, they have instructed Magellan Technology, the manufacturer of Hyde, to withdraw their product from the market.


The FDA has been working to regulate the extensive e-cigarette industry, which includes both established and start-up companies. Regulatory agencies have faced criticism from Congress and anti-e-cigarette advocates as they have missed multiple deadlines and have been unable to make decisions on compliance applications for millions of e-cigarette products submitted by companies.


In the past three years, federal and state laws and regulations have increased the purchasing age for tobacco and e-cigarette products, and have banned almost all small e-cigarette flavors that are popular among teenagers.


Some children may have also been scared away by the outbreak of illnesses and deaths related to e-cigarettes in 2019 - most of whom were associated with additives in black market e-liquids containing THC, a chemical that can produce a marijuana-like high when inhaled.


A leader of an advocacy organization has stated that their efforts to combat youth vaping have not been progressing well. These figures "may not reflect the larger reality of youth e-cigarette use that we hear about every day from parents, teachers, pediatricians, and prevention experts who are dealing with this urgent and ongoing youth public health crisis," said the organization, which is made up of parents opposed to vaping, in a statement.


Earlier this summer, the U.S. Food and Drug Administration (FDA) attempted to ban products from leading e-cigarette manufacturer Juul due to concerns about potential health risks. However, after a court challenge, the effort was forced to be put on hold. In a survey conducted this year, approximately one-fifth of teenage e-cigarette users reported using Juul recently, although it is no longer the most popular brand. This is a significant shift from 2019 when over half of young people's most commonly used e-cigarette was Juul.


On the contrary, many young people have turned to electronic cigarettes that offer laboratory-manufactured nicotine, including Puff Bar, which is a loophole in the FDA supervision that was shut down by Congress this year. Despite obtaining new authorization for these products, the FDA missed the mid-July deadline to make decisions on most products.


Statement:


This article is compiled from third-party information and is only intended for industry exchange and learning purposes.


This article does not reflect the views of 2FIRSTS and 2FIRSTS cannot confirm the authenticity and accuracy of the article's content. The translation of this article is intended solely for industry exchange and research.


Due to limitations in translation abilities, the translated article may not accurately reflect the original text. Please refer to the original text for accuracy.


2FIRSTS aligns completely with the Chinese government on any domestic, Hong Kong, Macau, Taiwan, and international issues and positions.


The compilation of information is subject to the ownership of the original media and author. If there is any infringement, please contact us for deletion.



Disclaimer

This article is provided solely for professional research, industry discussion, and informational purposes. Any references to brands, companies, products, technologies, or policies are made for factual reporting and analytical purposes only, and do not constitute endorsement, recommendation, promotion, or advertising by 2Firsts.

Nicotine-containing products, including but not limited to cigarettes, e-cigarettes, heated tobacco products, and nicotine pouches, carry significant health risks. Readers are responsible for complying with all applicable laws and regulations in their respective jurisdictions, including age restrictions and access limitations.

The information contained in this article should not be regarded as investment, legal, medical, regulatory, or commercial advice. While 2Firsts strives to ensure the accuracy and reliability of its content, it does not assume liability for any direct or indirect loss arising from errors, omissions, inaccuracies, or reliance on the information contained herein.

This article is not intended for individuals below the legal age for accessing tobacco or nicotine-related information in their jurisdiction.

 

Copyright Notice

This article is either original content produced by 2Firsts or content reproduced, translated, summarized, or adapted from third-party sources with attribution where applicable. The intellectual property rights of the original content remain with 2Firsts or the respective original rights holders.

No individual or organization may copy, reproduce, distribute, republish, modify, translate, or otherwise use this content without prior authorization. Any unauthorized use may result in legal action.

For copyright-related inquiries, corrections, or removal requests, please contact: info@2firsts.com.

 

AI-Assisted Translation and Editing Notice

Portions of this article may have been translated, edited, or reviewed with the assistance of artificial intelligence tools to improve efficiency and readability. Due to the limitations of AI-assisted translation and editing, discrepancies, omissions, or inaccuracies may exist when compared with the original source.

Where applicable, readers are advised to refer to the original source for the most complete and accurate information. If you identify any errors or believe that any content infringes upon your rights, please contact us at info@2firsts.com, and we will review and address the matter promptly.

NAS 2026 | FDA CTP Director Says PMTA Pathway Is “Predicated on Tobacco Harm Reduction”
NAS 2026 | FDA CTP Director Says PMTA Pathway Is “Predicated on Tobacco Harm Reduction”
At the 2026 New Approaches Summit in New York, FDA Center for Tobacco Products Director Bret Koplow said the PMTA pathway is “predicated on tobacco harm reduction.” He outlined four CTP priorities: youth prevention, helping adults quit or switch to lower-risk products, improving relative-risk communication, and reducing unauthorized products. Koplow also addressed flavored e-cigarettes, public risk perceptions, industry credibility and efforts to make PMTA reviews more efficient and predictable.
Sep.26
NAS 2026 | Former FDA Tobacco Chief Mitch Zeller Calls for Shift From “End Game” to “End State”
NAS 2026 | Former FDA Tobacco Chief Mitch Zeller Calls for Shift From “End Game” to “End State”
At the 2026 New Approaches Summit in New York, former FDA Center for Tobacco Products Director Mitch Zeller called for the tobacco harm reduction debate to shift from the traditional “end game” toward defining a desired “end state.” He also highlighted unresolved concerns around dual use, argued that biomarkers of exposure may be more meaningful than cigarettes-per-day in assessing risk reduction, and said nicotine misperceptions remain a major barrier to public health progress.
Sep.25
FDA Unifies Tobacco Registration and Product Listing Form Across Product Categories
FDA Unifies Tobacco Registration and Product Listing Form Across Product Categories
The U.S. FDA has consolidated two tobacco establishment registration and product listing forms into a redesigned Form FDA 3741 covering all regulated product categories, including e-cigarettes, heated tobacco products and nicotine pouches. The current requirements remain limited to domestic establishments. Separately, the FDA has proposed extending registration and product listing requirements to foreign manufacturers, signaling greater regulatory attention to manufacturing entities and product-level information across the tobacco and nicotine supply chain.
FDA
Sep.30
Special Report | How Capital Is Reassessing the Global Tobacco and Modern Nicotine Industry: Lessons from a New York Forum
Special Report | How Capital Is Reassessing the Global Tobacco and Modern Nicotine Industry: Lessons from a New York Forum
Capital is reassessing the global tobacco and modern nicotine industry as heated tobacco, vaping and nicotine pouches reshape demand, profitability and regulation. At the 2026 New Approaches Summit in New York, investors and analysts examined whether smoke-free growth can sustain earnings, how regulation shapes startup value, and whether shareholder engagement can be more effective than divestment. The debate points to a broader shift: tobacco transition is increasingly becoming a capital-allocation, governance and valuation question.
Capital Markets
Oct.05
Malaysia's Poisons Board Backs New Vape Nicotine Exemption After Unanimously Opposing 2023 Proposal
Malaysia's Poisons Board Backs New Vape Nicotine Exemption After Unanimously Opposing 2023 Proposal
Malaysia's Poisons Board has endorsed Health Minister Dzulkefly Ahmad's proposal to exempt liquid nicotine used in vaping products from the Poisons List, according to a November 2, 2026, report by CodeBlue. The Board unanimously opposed a similar proposal in 2023, but the government proceeded with the exemption. The Kuala Lumpur High Court invalidated the 2023 decision in May 2026, and the government withdrew its appeal in August. No new ministerial order has been published. The development raises questions about the interaction between Malaysia's two regulatory frameworks and the treatment of RM354.51 million in excise duties collected on e-cigarette and vape products between May 2023 and June 11, 2026.
Regulations
Nov.03
Australia Extends Illicit Tobacco Crackdown From Tougher Penalties to Customs and Logistics Supply Chains
Australia Extends Illicit Tobacco Crackdown From Tougher Penalties to Customs and Logistics Supply Chains
Australia's federal government introduced a new illicit tobacco enforcement bill on September 10 that would strengthen evidentiary presumptions, representative sampling, seizure and forfeiture procedures, proceeds-of-crime powers and obligations for customs and logistics operators. The proposal follows the Combatting Illicit Tobacco Act 2026, which took effect in August and increased penalties while expanding investigative and asset-recovery tools. Together, the reforms extend Australia's crackdown from tougher criminal sanctions into import, logistics and evidentiary enforcement.
Sep.14